Additional Testing for Chronic Leukocytosis and Lymphocytosis
For a patient with chronic elevation of White Blood Cell (WBC) count and lymphocytosis, a comprehensive hematologic workup should be performed to evaluate for potential lymphoproliferative disorders, particularly chronic lymphocytic leukemia (CLL).
Initial Laboratory Evaluation
- Complete blood count with manual differential to assess for other cytopenias, abnormal cell populations, and to confirm lymphocytosis 1, 2
- Peripheral blood smear review to identify morphology of lymphocytes and other abnormal cells 3, 2
- Comprehensive metabolic panel including liver and renal function tests 2
- Lactate dehydrogenase (LDH) as a marker for potential malignancy 3, 2
- Serum immunoglobulin levels and direct antiglobulin test (DAT) 3, 4
Specialized Testing for Lymphoproliferative Disorders
- Flow cytometry of peripheral blood for immunophenotyping to identify clonal B-cell populations (particularly important to evaluate for CLL which typically shows CD5+, CD19+, CD20+, CD23+ expression with dim surface immunoglobulin) 3, 4
- FISH analysis for detection of cytogenetic abnormalities, particularly deletion 17p [del(17p)] and deletion 11q [del(11q)], which have prognostic and therapeutic implications 3
- Molecular analysis for TP53 mutations, which has strong prognostic and predictive relevance 3
- Immunoglobulin heavy chain variable (IGHV) mutational status testing, which has strong prognostic value 3
Bone Marrow Evaluation
- Bone marrow aspiration and biopsy with immunohistochemistry if a lymphoproliferative disorder is suspected based on peripheral blood findings 3
- Conventional cytogenetics on bone marrow sample to detect complex karyotype and other chromosomal abnormalities 3, 5
- For CLL specifically, bone marrow examination is not required for diagnosis but is recommended for evaluation of unclear cytopenias 3
Imaging Studies
- CT scan of chest, abdomen, and pelvis with contrast if lymphoproliferative disorder is suspected to document extent of lymphadenopathy and organomegaly 3
- Ultrasound may be considered as an alternative for initial evaluation of superficial lymphadenopathy in elderly patients 3, 2
Additional Testing Based on Clinical Suspicion
- Serology testing for viral infections (HBV, HCV, CMV, HIV) that may be associated with reactive lymphocytosis or that need to be evaluated prior to potential treatment 3
- Serum protein electrophoresis and immunofixation if paraproteinemia is suspected (particularly for Waldenström macroglobulinemia) 6, 2
- Beta-2 microglobulin level, which is an important prognostic marker in CLL and other lymphoproliferative disorders 3, 6
Special Considerations
- For persistent unexplained lymphocytosis without clear evidence of CLL, consider testing for MYD88 L265P mutation which is strongly associated with Waldenström macroglobulinemia 6, 2
- If eosinophilia is present alongside lymphocytosis, consider testing for TK fusion gene rearrangements 7
- In cases where hemophagocytic lymphohistiocytosis (HLH) is suspected, additional testing including ferritin, triglycerides, and soluble IL-2 receptor levels should be considered 8
Common Pitfalls to Avoid
- Failure to exclude common causes of reactive lymphocytosis (viral infections, stress, medications) before pursuing extensive workup 9, 10
- Overlooking the need for flow cytometry, which is essential for distinguishing between reactive and neoplastic causes of lymphocytosis 4, 11
- Not considering smoking status, which can cause mild leukocytosis but typically affects neutrophils more than lymphocytes 12, 13
- Delaying bone marrow evaluation in patients with concerning peripheral blood findings 2